18-Oct-2026 10:04:12
BAJAJ HEALTHCARE Q2 FY27: STRONG GROWTH, FORMULATIONS UP 82% YOY 🟢
• FORMULATIONS REVENUE UP 82% YOY; API EXPORTS UP 28.5% YOY. • API EXPORTS + FORMULATIONS COMBINED REVENUE CROSSED ₹100 CR IN Q2. • GENRX ACQUISITION: RECEIVED…
Latest market headlines for BAJAJ HEALTHCARE on Terminal.
18-Oct-2026 10:04:12
• FORMULATIONS REVENUE UP 82% YOY; API EXPORTS UP 28.5% YOY. • API EXPORTS + FORMULATIONS COMBINED REVENUE CROSSED ₹100 CR IN Q2. • GENRX ACQUISITION: RECEIVED…